Theme Group Projects 2014
29/03/2014REPORT on the SANORD Conference in Uppsala, Sweden September 7-9, 2016
25/10/2016Deadline for submission: 29 May 2015
This funding instrument is open to scientists from all scientific fields and enables researchers from any country to carry out an ambitious research project in a reputable institution in France. The ANR funding is designed to help French laboratories fulfil their role as host and researchers to conduct their research. Further information: http://www.
Research and Innovation Staff Exchange (RISE) of Marie Sklodowska Curie Actions (Horizon 2020)
Deadline : 28 April 2015
The RISE scheme promotes international and inter-sector collaboration through research and innovation staff exchanges, and sharing of knowledge and ideas from research to market (and vice-versa) for the advancement of science and the development of innovation. RISE involves organisations from the academic and non-academic sectors (in particular SMEs), based in Europe (EU Member States and Associated Countries) and outside Europe (third countries). Support is provided for the development of partnerships in the form of joint research and innovation activities between the participants. Further information: http://ec.europa.
Kindly note that these calls are not coordinated by the Department. The contact details of the coordinator/ Project Manager at the French embassy are as follows (Please visit the links provided or contact the embassy for more information on the calls):
Aude ZULIANI
Scientific Project Manager
French Embassy in South Africa
250 Melk Street, Nieuw Muckleneuk – 0181 Pretoria
T: +27 (0)12 425 1672 / Cell: +27 (0)72 529 6013
science@ambafrance-rsa.org<
Uppsala Health Summit on Antibiotic Resistance to follow decision by WHO
Shortly after the World Health Organization (WHO) global action plan on antibiotic resistance has been adopted in May 2015, researchers, politicians and representatives from public health organizations and the pharmaceutical industry will gather in Uppsala, Sweden, to discuss the most urgent next steps. The growing problem of antibiotic resistance, which compromises our ability to treat common infections, represents one of the greatest threats to public health and security worldwide.
In May, the World Health Assembly (WHA) will decide on a “Global action plan on antimicrobial resistance”. The plan was requested by the same assembly last year and since then the WHO and the member states have worked on a draft plan.
Uppsala Health Summit: 2-3 June 2015
on Antibiotic Resistance to follow decision by WHO
Shortly after the World Health Organization (WHO) global action plan on antibiotic resistance has been adopted in May 2015, researchers, politicians and representatives from public health organizations and the pharmaceutical industry will gather in Uppsala, Sweden, to discuss the most urgent next steps.
The growing problem of antibiotic resistance, which compromises our ability to treat common infections, represents one of the greatest threats to public health and security worldwide.
In May, the World Health Assembly (WHA) will decide on a “Global action plan on antimicrobial resistance”. The plan was requested by the same assembly last year and since then the WHO and the member states have worked on a draft plan.
On June 2-3 the Uppsala Health Summit will gather experts, stakeholders, international public health organizations, national agencies and governments, the international research community, NGOs (non-governmental organizations) and pharmaceutical and diagnostic companies for a dialogue on how to embark on the Global action plan. The program is available here: http://www.